National Institutes of Health
503
6M
40
3.75
183
0.24
8
- Stages of investment
- Areas of investment
Summary
National Institutes of Health appeared to be the Corporate Investor, which was created in 1887. The leading representative office of defined Corporate Investor is situated in the Bethesda. The venture was found in North America in United States.
Besides, a startup needs to be aged 16-20 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical, Medical Device. Among the most popular portfolio startups of the fund, we may highlight 23andMe, Neurotrack, Second Sight. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.
The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2016. Considering the real fund results, this Corporate Investor is 31 percentage points more often commits exit comparing to other organizations. The typical startup value when the investment from National Institutes of Health is 1-5 millions dollars. Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in 13-24 deals per year. Opposing the other organizations, this National Institutes of Health works on 18 percentage points less the average amount of lead investments.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the National Institutes of Health, startups are often financed by U.S. Department of Defense, New Enterprise Associates, 5AM Ventures. The meaningful sponsors for the fund in investment in the same round are National Science Foundation, National Institute of Allergy and Infectious Diseases, Small Business Innovation Research. In the next rounds fund is usually obtained by U.S. Department of Defense, Golden Angels Investors, Wisconsin Investment Partners.
Investments analytics
Analytics
- Total investments
- 503
- Lead investments
- 183
- Exits
- 8
- Rounds per year
- 3.75
- Follow on index
- 0.24
- Investments by industry
- Biotechnology (34)
- Health Care (22)
- Medical (15)
- Medical Device (11)
- Therapeutics (10) Show 33 more
- Investments by region
-
- United States (43)
- Zambia (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 25
- Avg. valuation at time of investment
- 9M
- Group Appearance index
- 0.91
- Avg. company exit year
- 13
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Fineway | 30 Aug 2019 | Artificial Intelligence, SaaS, Travel | Early Stage Venture | 15M | Bayern, Munich, Germany |
| Graphika | 13 Jan 2014 | Analytics, Content, Marketing, Social Media, Text Analytics | Seed | 3M | United States, New York, New York |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.